Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis

Nr4a1-Dependent Ly6Clow Monocytes Monitor Endothelial Cells and Orchestrate Their Disposal

(2013) Leo M. Carlin et al.   CELL

Sjögren's syndrome and the epithelial target: A comprehensive review

(2013) M.J. Barrera et al.   JOURNAL OF AUTOIMMUNITY

Classification criteria for Sjögren's syndrome: we actually need to definitively resolve the long debate on the issue

(2012) Claudio Vitali et al.   ANNALS OF THE RHEUMATIC DISEASES

Sex steroids in Sjögren’s syndrome

(2012) Yrjö T. Konttinen et al.   JOURNAL OF AUTOIMMUNITY

Sjogren’s syndrome: An update on clinical, basic and diagnostic therapeutic aspects

(2012) A.G. Tzioufas et al.   JOURNAL OF AUTOIMMUNITY

VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses

(2012) Catalina Abad et al.   PLoS One

RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: Immune regulation by vasoactive intestinal peptide

(2011) Mar Carrión et al.   ARTHRITIS AND RHEUMATISM

Targeting VIP and PACAP Receptor Signalling: New Therapeutic Strategies in Multiple Sclerosis

(2011) Yossan-Var Tan et al.   ASN Neuro

VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins

(2011) Alain Couvineau et al.   BRITISH JOURNAL OF PHARMACOLOGY

Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome

(2011) V. Hauk et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

The complexity of Sjögren's syndrome: Novel aspects on pathogenesis

(2011) Roland Jonsson et al.   IMMUNOLOGY LETTERS

Disturbances of apoptotic cell clearance in systemic lupus erythematosus

(2011) Wen-Hai Shao et al.   ARTHRITIS RESEARCH & THERAPY

Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial

(2010) J. M. Meijer et al.   ARTHRITIS AND RHEUMATISM

The role of intrinsic epithelial activation in the pathogenesis of Sjögren’s syndrome

(2010) Menelaos N. Manoussakis et al.   JOURNAL OF AUTOIMMUNITY

Modulation of macrophage inflammatory profile in pregnant nonobese diabetic (NOD) mice

(2010) Luciana Larocca et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome

(2010) Michael Voulgarelis et al.   Nature Reviews Rheumatology

Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis

(2010) C. Abad et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Toll-like receptor stimulation differentially regulates vasoactive intestinal peptide type 2 receptor in macrophages

(2009) Juan Luis Herrera et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Vasoactive intestinal peptide inhibits TNF-α-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands

(2009) Mario Calafat et al.   ARTHRITIS RESEARCH & THERAPY

Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts

(2008) Yasmina Juarranz et al.   ARTHRITIS AND RHEUMATISM

Identification of possible candidate genes regulating Sjögren's syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy

(2008) Cuong Q Nguyen et al.   ARTHRITIS RESEARCH & THERAPY